alpha-glutamyltryptophan,
Glu-Trp,
L-alpha-glutamyl-L-tryptophan,
Oglufanide,
H-Glu-Trp-OH,
38101-59-6,
Thymogen,
Glutamyltryptophan,
Glu-trp,
alpha-Glutamyltryptophan,
Timogen,
L-glutamyl-L-tryptophan,
Glutamyl tryptophan,
Oglufanide [INN],
L-Glu-L-Trp,
L-alpha-Glutamyl-L-tryptophan,
alpha-Glu-Trp,
UNII-4RHY598T5U,
IM 862,
L-alpha-Glu-L-Trp,
IM862,
NSC 334073,
4RHY598T5U,
CHEBI:73512,
L-Tryptophan, L-alpha-glutamyl-,
L-Tryptophan, N-L-alpha-glutamyl-,
C16H19N3O5,
CCRIS 8677,
EW dipeptide,
NSC334073,
E-W Dipeptide,
AK327659,
IM 862 dipeptide,
AC1L2O1M,
Glutamate Tryptophan dipeptide,
Glutamate-Tryptophan dipeptide,
L-Tryptophan, L-a-glutamyl-,
SCHEMBL1898073,
CHEMBL2111029,
KS-00000GDS,
BCP13098,
ZINC1576166,
MFCD00037953,
AKOS026751470,
API0003667,
CS-5654,
DB05779,
122933-59-9,
AS-49440,
HY-13718,
LS-158146,
LS-172546,
FT-0771477,
C-48461,
(4S)-4-[N-((1S)-1-carboxy-2-indol-3-ylethyl)carbamoyl]-4-aminobutanoic acid,
(S)-4-amino-5-((S)-1-carboxy-2-(1H-indol-3-yl)ethylamino)-5-oxopentanoic acid,
(4S)-4-amino-5-[[(2S)-1-hydroxy-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid,
Glufanide disodium,
Oglufanide disodium,
D02RNS,
im-862,
Kaposis sarcoma therapy, Cytran,
CID100094,
C16-H19-N3-O5,